Answer
It may increase the risk of solid-organ rejection and can cause serious complications around donor stem-cell transplantation. Decisions require close input from oncology and transplant specialists.
Sources for this answer
- KEYTRUDA 25 mg/mL concentrate for solution for infusion — Current selected SmPCemc · Summary of Product Characteristics
- UK GovernmentUK Government · Reputable Web
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.